J
John W. Earl
Researcher at Children's Hospital at Westmead
Publications - 43
Citations - 1400
John W. Earl is an academic researcher from Children's Hospital at Westmead. The author has contributed to research in topics: Melphalan & Population. The author has an hindex of 24, co-authored 43 publications receiving 1266 citations. Previous affiliations of John W. Earl include Boston Children's Hospital & Alexandra Hospital.
Papers
More filters
Journal ArticleDOI
Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation
TL;DR: Cerebrospinal fluid neopterin production is increased by interferon‐gamma stimulation and appears to act as a marker of intrathecal immune activation and may be a biological marker of central nervous system (CNS) inflammation.
Journal ArticleDOI
Population Pharmacokinetics of Liposomal Amphotericin B in Pediatric Patients with Malignant Diseases
Ying Hong,Peter J. Shaw,Christa E. Nath,Satya Prakash Yadav,Katherine R. Stephen,John W. Earl,Andrew J. McLachlan +6 more
TL;DR: The model has been evaluated and can be used in the design of rational dosing strategies for L-AmB antifungal therapy in this special population of pediatric patients with malignant diseases.
Journal ArticleDOI
Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5′-phosphate availability
Shanti Balasubramaniam,Frank Bowling,Kevin Carpenter,Kevin Carpenter,John W. Earl,Jeffrey Chaitow,James Pitt,James Pitt,Etienne Mornet,David Sillence,David Sillence,Carolyn Ellaway,Carolyn Ellaway +12 more
TL;DR: Two neonates presenting with perinatal hypophosphatasia and severe epileptic encephalopathy resulting in death had increased levels of urinary vanillactate, indicating functional deficiency of aromatic amino acid decarboxylase, a pyridoxal-5-phosphate (PLP)-dependent enzyme required for dopamine and serotonin biosynthesis.
Journal ArticleDOI
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
Christa E. Nath,Peter J. Shaw,Peter J. Shaw,Judith Trotman,L. Zeng,Stephen B. Duffull,Gareth Hegarty,Andrew J. McLachlan,Andrew J. McLachlan,Howard Gurney,Ian Kerridge,Yiu Lam Kwan,Peter Presgrave,Campbell Tiley,Douglas E. Joshua,John W. Earl +15 more
TL;DR: Creatinine clearance, fat free mass and haematocrit influence total and unboundmelphalan plasma clearance, andMelphalan exposure is related to melphalan toxicity while the association with efficacy shows promising trends that will be studied further.
Journal ArticleDOI
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
Kavitha Kothur,Louise Wienholt,Esther M Tantsis,John W. Earl,Sushil Bandodkar,Kristina Prelog,Fiona Tea,Sudarshini Ramanathan,Fabienne Brilot,Russell C. Dale +9 more
TL;DR: The findings suggest that MOG Ab POS patients have a more pronounced CNS inflammatory response with elevation of predominant humoral associated cytokines/chemokines, as well as some Th 17 and neutrophil related cytokines and chemokines suggesting a differential inflammatory pathogenesis associated with MOG antibody seropositivity.